Global RTSM Leader Suvoda, formed from a merger with Greenphire, positions as a global clinical trial technology leader with end-to-end RTSM, eCOA, eConsent, patient payments, and travel solutions, presenting cross-sell opportunities to sponsors seeking integrated trial platforms.

Awarded Patient Focus Recent MedTech Breakthrough awards for the patient app highlight strong patient engagement capabilities, suggesting upsell potential to sponsors prioritizing patient-centric data capture, retention, and experience improvements.

Efficiency Frontier Launch of agentic RTSM and claims of reducing startup timelines by up to 80 percent signal a compelling value proposition for sponsors facing tight study timelines and cost pressures.

Scale and Stability With a mid-market to enterprise footprint (200–500 employees) and revenue in the high hundreds of millions, Suvoda offers scalable technology and services suitable for mid-to-large pharma and biotech sponsors seeking robust global support.

Integrated Patient Experience Unified patient app and logistics-focused patient journey solutions enable cross-sell into patient recruitment, data capture, and site support, appealing to sponsors aiming to streamline participant experience across sites.